Brief: Nykode Therapeutics Q2 Net Loss Widens To $8.7 Million
Aug 24 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* Q2 TOTAL REVENUE AND OTHER INCOME USD 3.4 MILLION VERSUS
USD 1.9
MILLION YEAR AGO
* Q2 OPERATING LOSS USD 10.2 MILLION VERSUS LOSS USD 7.7
MILLION
YEAR AGO
* Q2 NET LOSS FOR PERIOD USD 8.7 MILLION VERSUS LOSS USD 6.2
MILLION YEAR AGO
Source text for Eikon: ID:nObifYfJla
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026